cognitive cybersecurity intelligence

News and Analysis

Search

Cancer therapeutics company double win with $25M and board member

An mRNA-technology company developing cancer therapeutics designed to improve patients’ survival rate and quality of life — this week announced the completion of a $25 million Series A financing.

Kernal Biologics, Inc. (Kernal Bio)  confirmed that the funding was  led by…

Source: www.labiotech.euRead more

Subscribe to newsletter

Subscribe to HEAL Security Dispatch for the latest healthcare cybersecurity news and analysis.

More Posts

Quantum Threats Preparing Your Encryption Strategy

Quantum Threats Preparing Your Encryption Strategy

As quantum computing advances, existing encryption methods face obsolescence, prompting urgent implementation of post-quantum cryptography (PQC). Experts predict “Q-Day,” when quantum computers can break current